Recombinant Human Grb2 Protein (HEK293)，His

Grb2 (Growth factor receptor-bound protein 2) is a key adaptor protein involved in various cellular signaling pathways, particularly those associated with growth factor receptor activation. Its primary role is to mediate signal transduction from receptor tyrosine kinases (RTKs) to downstream effectors, including the Ras-MAPK pathway, which is crucial for cellular processes such as proliferation, differentiation, and survival. Research into Grb2 recombinant protein has gained significant attention due to its central role in oncogenesis and various diseases, including cancer. The ability to produce Grb2 as a recombinant protein allows for detailed biochemical characterization, including studies on its binding affinities and interaction with other signaling molecules. Additionally, understanding the structural dynamics of Grb2 through methods such as X-ray crystallography or NMR spectroscopy can provide insights into its functional mechanisms. Furthermore, the development of Grb2 inhibitors or modulators holds therapeutic potential, particularly in targeting cancers that exhibit aberrant RTK signaling. Thus, the study of Grb2 recombinant protein is essential for elucidating its role in cellular signaling and for advancing potential therapeutic strategies aimed at diseases related to dysregulated signaling pathways. This research can ultimately contribute to the identification of novel drug targets, enhancing our understanding of cellular communications and pathophysiological conditions associated with Grb2 activity.